HKSE:02138 (Hong Kong)
Â
Shs Unitary 144A/Reg S
HK$
0.63
(0%)
Apr 17
What is a stock summary page? Click here for an overview.
Business Description
EC Healthcare
ISIN : KYG9320L1005
Share Class Description:
HKSE:02138: Shs Unitary 144A/Reg SCompare
Compare
Traded in other countries / regions
02138.Hong Kong1UM0.GermanyUNHLF.USA Index Membership
Hong Kong Stock Connect IPO Date
2016-03-11Description
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare, and beauty products. The group caters to its services through the operating segments of Medical which is the key revenue generator segment and Aesthetic medical, beauty and wellness, and Veterinary and others. Geographically, the group has a business presence in Hong Kong, Macau, and the PRC.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.55 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 0.75 | |||||
Debt-to-EBITDA | 1.98 | |||||
Interest Coverage | 1.89 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.96 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.8 | |||||
3-Year EBITDA Growth Rate | 2.6 | |||||
3-Year EPS without NRI Growth Rate | -70.3 | |||||
3-Year FCF Growth Rate | -0.9 | |||||
3-Year Book Growth Rate | 12.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 76.67 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.12 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.81 | |||||
9-Day RSI | 44 | |||||
14-Day RSI | 43.48 | |||||
3-1 Month Momentum % | 19.35 | |||||
6-1 Month Momentum % | -6.33 | |||||
12-1 Month Momentum % | -40.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.08 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 63.38 | |||||
Days Sales Outstanding | 25.7 | |||||
Days Payable | 41.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.59 | |||||
Dividend Payout Ratio | 1.25 | |||||
3-Year Dividend Growth Rate | -24.7 | |||||
Forward Dividend Yield % | 1.59 | |||||
5-Year Yield-on-Cost % | 0.74 | |||||
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -1.81 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 83.13 | |||||
Operating Margin % | 4.99 | |||||
Net Margin % | -0.28 | |||||
FCF Margin % | 19.1 | |||||
ROE % | -0.59 | |||||
ROA % | -0.21 | |||||
ROIC % | 3.79 | |||||
3-Year ROIIC % | -1.37 | |||||
ROC (Joel Greenblatt) % | 10.74 | |||||
ROCE % | 3.79 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 63 | |||||
PE Ratio without NRI | 157.5 | |||||
Shiller PE Ratio | 3 | |||||
Price-to-Owner-Earnings | 1.63 | |||||
PEG Ratio | 43.75 | |||||
PS Ratio | 0.15 | |||||
PB Ratio | 0.37 | |||||
Price-to-Tangible-Book | 1.7 | |||||
Price-to-Free-Cash-Flow | 0.97 | |||||
Price-to-Operating-Cash-Flow | 0.97 | |||||
EV-to-EBIT | 13.13 | |||||
EV-to-Forward-EBIT | 8.01 | |||||
EV-to-EBITDA | 2.56 | |||||
EV-to-Revenue | 0.47 | |||||
EV-to-Forward-Revenue | 0.5 | |||||
EV-to-FCF | 2.41 | |||||
Price-to-GF-Value | 0.06 | |||||
Price-to-Projected-FCF | 0.12 | |||||
Price-to-Graham-Number | 3.5 | |||||
Earnings Yield (Greenblatt) % | 7.62 | |||||
FCF Yield % | 107.15 | |||||
Forward Rate of Return (Yacktman) % | 54.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EC Healthcare Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 4,152.619 | ||
EPS (TTM) (HK$) | -0.01 | ||
Beta | 1.62 | ||
3-Year Sharpe Ratio | -1.03 | ||
3-Year Sortino Ratio | -1.33 | ||
Volatility % | 49.69 | ||
14-Day RSI | 43.48 | ||
14-Day ATR (HK$) | 0.032476 | ||
20-Day SMA (HK$) | 0.6595 | ||
12-1 Month Momentum % | -40.32 | ||
52-Week Range (HK$) | 0.53 - 2.18 | ||
Shares Outstanding (Mil) | 1,175.25 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EC Healthcare Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EC Healthcare Stock Events
Event | Date | Price (HK$) | ||
---|---|---|---|---|
No Event Data |
EC Healthcare Frequently Asked Questions
What is EC Healthcare(HKSE:02138)'s stock price today?
The current price of HKSE:02138 is HK$0.63. The 52 week high of HKSE:02138 is HK$2.18 and 52 week low is HK$0.53.
When is next earnings date of EC Healthcare(HKSE:02138)?
The next earnings date of EC Healthcare(HKSE:02138) is .
Does EC Healthcare(HKSE:02138) pay dividends? If so, how much?
The Dividend Yield %  of EC Healthcare(HKSE:02138) is 1.59% (As of Today), Highest Dividend Payout Ratio of EC Healthcare(HKSE:02138) was 15.67. The lowest was 0.21. And the median was 0.88. The  Forward Dividend Yield % of EC Healthcare(HKSE:02138) is 1.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |